title: Effects of omalizumab in Aspergillus-associated airway disease.
authors.forename: L A
authors.initials: LA
authors.lastname: Pérez-de-Llano
authors.forename: M C
authors.initials: MC
authors.lastname: Vennera
authors.forename: A
authors.initials: A
authors.lastname: Parra
authors.forename: J
authors.initials: J
authors.lastname: Guallar
authors.forename: M
authors.initials: M
authors.lastname: Marin
authors.forename: O
authors.initials: O
authors.lastname: Asensio
authors.forename: P
authors.initials: P
authors.lastname: Ausin
authors.forename: L
authors.initials: L
authors.lastname: Borderías
authors.forename: C
authors.initials: C
authors.lastname: Fernández
authors.forename: C
authors.initials: C
authors.lastname: Granel
authors.forename: A
authors.initials: A
authors.lastname: Pérez-Pimiento
authors.forename: M
authors.initials: M
authors.lastname: Rubio
mesh_terms: D000328:Adult; D000368:Aged; D018926:Anti-Allergic Agents / Q000627:therapeutic use*; D000888:Antibodies, Anti-Idiotypic / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D000069444:Omalizumab; D055732:Pulmonary Aspergillosis / Q000188:drug therapy*; D012189:Retrospective Studies; D016896:Treatment Outcome
chemical_list: D018926:Anti-Allergic Agents; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D005938:Glucocorticoids; D000069444:Omalizumab